Andere Sprachen Notable Labs, Ltd.

Aktien

A119YE

IL0012002452

NTBL

Schlusskurs Nasdaq Andere Börsenplätze 00:00:00 25.04.2024			% 5 Tage	% 1. Jan.
0.9601 ^USD	-2.13%		-1.53%	-49.20%

15.04.	NOTABLE LABS, LTD. : Chardan Research behält die Bewertung Kaufen bei	ZM
15.04.	NOTABLE LABS, LTD. : Chardan Research gibt eine Kauf-Bewertung ab	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Notable Labs Reports 2023 Financial Results and Provides a Business Update	15.04.
Notable Labs Reports 2023 Financial Results and Provides a Business Update	12.04.
VASR BIOG : AACR 2024 VOLA Poster	09.04.
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024	09.04.
Notable Labs, Ltd. Presents the Design Plan for the Ppmp-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024	09.04.
VASR BIOG : AACR 2024 Poster	08.04.
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the Platform	08.04.
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay At AACR 2024 Expands the Potential of the Platform	08.04.
OPINIONES DE LOS ANALISTAS DEL DÍA : Stellantis, Aena, Richemont, Adyen, Fraport, BBVA, Aperam, Enagás, Sacyr, BE Semi...	02.04.
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform	05.03.
Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment	22.02.
Notable Labs, Ltd. Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment	22.02.
Top Premarket Gainers	09.01.
Notable Reports Predictive Precision Medicine Platform (PPMP) Accurately Predicted Fosciclopirox Trial Outcome	18.12.
Notable Labs, Ltd. and CicloMed LLC Announces Initial Safety and Efficacy Data of Fosciclopirox and the Performance of PPMP	18.12.
Notable Labs to Participate in JMP Securities Hematology and Oncology Summit	04.12.
Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023	14.11.
Notable Labs Announces JCO Precision Oncology Publication Demonstrating PPMP Potential to Identify Novel Drug Combinations in JMML	09.11.
VASR BIOG : Letter from the CEO...	09.11.
Vascular Biogenics, Notable Labs Complete Merger	16.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Notable Labs, Ltd.

Aktien

A119YE

IL0012002452

NTBL

Andere Sprachen

Filter